Loyola University Chicago · Microbiology & ImmunologyInnovative Vaccine Research Unit
Liang Qiao · Chicago, Illinois
Research Focus
Dr. Liang Qiao's lab at Loyola University Chicago focuses on developing innovative vaccines to combat viral infections, particularly coronaviruses and flaviviruses like Zika and dengue. The research aims to create safer vaccines that generate strong T cell responses without the risk of severe side effects associated with traditional antibody-based vaccines. The lab employs advanced techniques to enhance vaccine efficacy and develop mucosal delivery methods for protective immune responses.
vaccine developmentcoronavirusesZika virusdengue virusT cell responsesmucosal immunizationubiquitinationviral infectionimmune memory
Research Aims
5AIM 01Develop a mucosal vaccine for future emerging coronaviruses targeting specific proteins.
AIM 02Create a T cell-based vaccine for Zika and dengue viruses to avoid severe side effects.
AIM 03Evaluate the vaccine's effectiveness in mouse models against T cell responses.
AIM 04Assess the long-term immunity generated by the new vaccines.
AIM 05Utilize papillomavirus-like particles to enhance immune responses.
Skills the Lab Values
cell culturemolecular cloningplasmid constructionanimal modelsimmunization techniquesflow cytometryviral titrationgenetic engineeringprotein purification
Output against the department
Publications303top 16% of dept.77th of 486
this lab
most publishedleast published
Citations11ktop 33% of dept.162nd of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.